Roth Capital Upgrades Spectrum Pharmaceuticals (SPPI) to Buy
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 0 | New: 0
Join SI Premium – FREE
Roth Capital upgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Neutral to Buy, price target raised from $11 to $20.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $14.99 yesterday.
For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $14.99 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Bystronic AG (BYS:SW) to Neutral
- Citi Upgrades Informa Plc (INF:LN) (IFJPY) to
- Barclays Upgrades uniQure BV (QURE) to Overweight Following 78% Gain Yesterday
Create E-mail Alert Related Categories
UpgradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
